Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation
Cited 0 time in
- Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation
- Young S Choe; Chang Seob Shim; Dong Chan Choi; Chul Sang Lee; Kyung Kwang Lee; Kyungjin Kim
- Bibliographic Citation
- Molecular Reproduction and Development, vol. 48, no. 2, pp. 261-266
- Publication Year
- Galectin-1 is a member of β-galactoside-binding lectins expressed in a variety of mammalian tissues. We report here that galectin-1 mRNA is abundantly expressed in the mouse reproductive organs such as the uterus and ovary. Uterine expression of galectin-1 mRNA is specifically regulated in the embryonic implantation process. Its expression increased at a high level on the fifth day post coitum (dpc 5) when embryos hatched into the endometrial epithelial cells. In the absence of embryos, however, galectin-1 expression in the mouse uterus decreased on dpc 5. In the delayed implantation mice, galectin-1 mRNA level was augmented by the termination of the delay of implantation. Ovarian steroids progesterone and estrogen differentially regulated galectin-1 mRNA level in uterine tissues. Treatment with RU486, e progesterone receptor antagonist, blocked progesterone-induced galectin-1 mRNA level in uterine tissues of ovariectomized mouse. ICI182780, a pure estrogen receptor antagonist, clearly blocked the estrogen effect. Taken together, galectin-1 gene expression in the uterine tissues was regulated by ovarian steroids and this regulation correlated with the implantation process.
- galectin-1implantation17β-estradiolprogesteroneanti-steroidsgene regulation
- Appears in Collections:
- 1. Journal Articles > Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.